(NaturalNews) Major Alzheimer’s trials find semaglutide fails to slow cognitive decline. The study followed thousands with early Alzheimer’s or mild impairme…
Semaglutide fails to slow Alzheimer’s in major trials, dealing a blow to pharma’s wonder-drug narrative
Estimated read time
1 min read
You May Also Like
More From Author
Magnesium Linked to Lower Atrial Fibrillation Risk, Study Finds
November 16, 2026
U.S. Data Center Restrictions May Benefit Bitcoin Miners’ AI Ambitions
November 16, 2026
